[1]
“Development and Evaluation of a Chitosan-based Topical Gel of Dinalbuphine sebacate for Targeted Management of Rheumatoid Arthritis”,
AJP
, vol. 19, no. 2, Jul. 2025, doi:
10.22377/ajp.v19i2.6471
.